142 related articles for article (PubMed ID: 37055901)
1. Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds.
Xiaohelaiti H; Wu W; Gao Y; Li S; Ma C
Anticancer Agents Med Chem; 2023; 23(14):1644-1651. PubMed ID: 37055901
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C
Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors.
Wang YT; Shi TQ; Zhu HL; Liu CH
Bioorg Med Chem; 2019 Feb; 27(3):502-515. PubMed ID: 30606674
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives.
Ren B; Liu RC; Ji K; Tang JJ; Gao JM
Bioorg Med Chem Lett; 2021 Jul; 43():128097. PubMed ID: 33979690
[TBL] [Abstract][Full Text] [Related]
6. 1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies.
Anichina K; Argirova M; Tzoneva R; Uzunova V; Mavrova A; Vuchev D; Popova-Daskalova G; Fratev F; Guncheva M; Yancheva D
Chem Biol Interact; 2021 Aug; 345():109540. PubMed ID: 34139148
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
9. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.
Krstulović L; Leventić M; Rastija V; Starčević K; Jirouš M; Janić I; Karnaš M; Lasić K; Bajić M; Glavaš-Obrovac L
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677600
[TBL] [Abstract][Full Text] [Related]
10. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold.
Xu Q; Sun M; Bai Z; Wang Y; Wu Y; Tian H; Zuo D; Guan Q; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2017 Oct; 139():242-249. PubMed ID: 28802124
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents.
Zhang YL; Yang R; Xia LY; Man RJ; Chu YC; Jiang AQ; Wang ZC; Zhu HL
Bioorg Chem; 2019 Nov; 92():103219. PubMed ID: 31476616
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
14. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2,3,4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors.
Salehi M; Amini M; Ostad SN; Riazi GH; Assadieskandar A; Shafiei B; Shafiee A
Bioorg Med Chem; 2013 Dec; 21(24):7648-54. PubMed ID: 24238904
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis,
Hussein SAA; Kubba A; Balakit AA; Tahtamouni LH; Abbas AH
Med Chem; 2023; 19(10):1018-1036. PubMed ID: 37259214
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)-
Ahsan MJ; Gautam K; Ali A; Ali A; Altamimi ASA; Salahuddin ; Alossaimi MA; Lakshmi SVVNSM; Ahsan MF
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836779
[TBL] [Abstract][Full Text] [Related]
18. Characterization of novel heterocyclic compounds based on 4-aryl-4H-chromene scaffold as anticancer agents: Design, synthesis, antiprofilerative activity against resistant cancer cells, dual β-tubulin/c-Src inhibition, cell cycle arrest and apoptosis induction.
Abdelall EKA; A H Elshemy H; Labib MB; E A Mohamed F
Bioorg Chem; 2022 Mar; 120():105591. PubMed ID: 34998122
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]